Posted on 6/15/17
MilliporeSigma Expands Distribution Agreement with Public Health England
MilliporeSigma today announced an expansion of its distribution alliance with Public Health England (PHE) to include the European Bank for induced pluripotent Stem Cells (EBiSC)—a comprehensive . . .
Posted on 6/15/17
Frost & Sullivan Names Seven Bridges the Product Leader in Genomics Informatics
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Seven Bridges, the leader in biomedical data analysis, today announced it had received the Frost & Sullivan Product Leadership Award for the Genomics Informatics . . .
Posted on 6/15/17
Dicerna Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA), a leading developer of investigational ribonucleic acid interference (RNAi) therapeutics, today announced that based on recommendations from the Compensation . . .
Posted on 6/15/17
Dr. Una Ryan Joins Elemental Machines Board of Directors
Elemental Machines today announced that the distinguished Dr. Una Ryan, OBE has joined its Board of Directors.
Posted on 6/15/17
Bristol-Myers Squibb: Still Too Many Uncertainties In The I/O Space
In spite of the share price falling more than 30% since mid-2016 after disappointing results for Opdivo in lung cancer in the Checkmate-026 study, I don't . . .
Posted on 6/15/17
EyeGate Announces Completion of $10.0 Million Public Offering
WALTHAM, Mass., June 14, 2017 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG), a specialty pharmaceutical company that focuses on developing and commercializing products for treating diseases . . .
Posted on 6/15/17
Cue Biopharma to Present at 2017 BIO International Convention
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cue Biopharma, Inc., an immunotherapy company developing biologics engineered to selectively modulate disease-relevant T cell subsets to treat cancer and autoimmune disease, announced today . . .
Posted on 6/14/17
Excitement from ASCO: TG Thereapeutics, Loxo Oncology, and Bluebird Bio
Clinical-stage biotech companies put their best foot forward at the annual American Society of Clinical Oncology meeting earlier this week, but while many companies released data, . . .
Posted on 6/14/17
Loxo Oncology Announces Proposed Public Offering
STAMFORD, Conn., June 13, 2017 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically . . .
Posted on 6/13/17
Yield10 Bioscience Regains Compliance with NASDAQ Minimum Bid Price Listing Requirement
WOBURN, Mass., June 13, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) announced today that it has received a letter from The NASDAQ Stock Market LLC . . .
Posted on 6/13/17
Simione Healthcare Consultants and ClinLogica Announce Collaboration
Two leading organizations in healthcare consulting and technology have announced a partnership designed to transform quality and lower hospitalization risk along the continuum of care through . . .
Posted on 6/13/17
Dragonfly Therapeutics Announces Strategic Collaboration with Celgene
Dragonfly Therapeutics, Inc. announced a global strategic collaboration with Celgene Corporation and its affiliates to discover, develop and commercialize innovative immuno-oncology treatment options for patients with hematological . . .
Posted on 6/13/17
Fundación MAPFRE Partners with Boston Children's Hospital on Injury Prevention Program
More than 29 million children under 15 years-old are treated for unintentional injuries at US emergency departments each year, and more than 4,044 die from those . . .
Posted on 6/13/17
Alnylam Significantly Expands Patent Portfolio with New Allowances from United States Patent and Trademark Office
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced that the United States Patent and Trademark Office (USPTO) has issued Notices . . .
Posted on 6/12/17
CBSET and CILcare Partner
LEXINGTON, Mass.--(BUSINESS WIRE)--CBSET Inc., a non-profit research institute that specializes in the advancement of novel therapies, announced today that it has expanded its preclinical research service . . .
Posted on 6/10/17
Fallon Ambulance Service Receives American Heart Association’s Mission
Fallon Ambulance Service is the only Massachusetts EMS-Ambulance to receive the 2017 American Heart Association’s Mission: Lifeline® EMS Gold Plus Award for implementing quality improvement measures . . .
Posted on 6/9/17
EyeGate Announces $10.0 Million Public Offering
WALTHAM, Mass., June 09, 2017 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG), a specialty pharmaceutical company that focuses on developing and commercializing products for treating diseases . . .
Posted on 6/9/17
Staples (SPLS) Presents At Baird's Global Consumer, Technology & Services Conference - Slideshow
The following slide deck was published by Staples, Inc. in conjunction with this event. 120READ FULL ARTICLE HERE
Posted on 6/9/17
Biogen (BIIB) Investor Presentation - Slideshow
The following slide deck was published by Biogen Inc. in conjunction with this event. 113READ FULL ARTICLE HERE
Posted on 6/9/17
Aptuit Announces Strategic Provider Agreement with Regulus Therapeutics
Dr. Jonathan Goldman, CEO, Aptuit LLC, announced a strategic provider relationship between Aptuit, a leading Partnership Research Organization, and Regulus Therapeutics Inc (Nasdaq: RGLS), an innovative . . .
Posted on 6/9/17
Ezras Choilim Health Center Selects eClinicalWorks Cloud-Based EHR for Its 36 Providers
WESTBOROUGH, Mass.--(BUSINESS WIRE)--eClinicalWorks®, a leader in healthcare IT solutions, today announces that Ezras Choilim Health Center, a non-profit, federally qualified health center (FQHC), has selected eClinicalWorks . . .
Posted on 6/8/17
Why Sarepta Therapeutics Stock Imploded in May
What happenedShares of the rare-disease drugmaker Sarepta Therapeutics (NASDAQ:SRPT) crashed and burned in May seemingly due to nothing more than a lawsuit filed by a reporter . . .
Posted on 6/8/17
Cellceutix Announces Company Name Change to Innovation Pharmaceuticals Inc.
BEVERLY, Mass., June 07, 2017 (GLOBE NEWSWIRE) -- Cellceutix Corporation, (OTCQB:CTIX), an emerging biopharmaceutical company, is pleased to announce to shareholders, and the public at large, . . .
Posted on 6/8/17
Aptuit Announces Strategic Provider Agreement with Regulus Therapeutics
Dr. Jonathan Goldman, CEO, Aptuit LLC, announced a strategic provider relationship between Aptuit, a leading Partnership Research Organization, and Regulus Therapeutics Inc (Nasdaq:RGLS), an innovative biopharmaceutical . . .
Posted on 6/7/17
Peak Physical Therapy & Sports Performance Provides Fall Prevention Lecture at Active Day of Hingham
Peak Physical Therapy & Sports Performance, a South Shore practice specializing in unique programs that provide a comprehensive approach to treatment in orthopedic, spine and sports . . .
Boston
